The European Investment Bank (EIB) is going to support the AI-platform of NMR/metabolomics diagnostics company Numares AG to improve disease prediction.
https://european-biotechnology.com/wp-content/uploads/2024/04/Numares.jpg8671866Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-12-20 09:50:232024-07-15 13:03:19Numares AG cashes in €20m from EIB